A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study

Clinical trial NCT03042013 · WITHDRAWN

Trial details

NCT number: NCT03042013
Sponsor: Astellas Pharma Global Development, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Subjects With NSCLC With an EGFR Activating Mutation

Start date: 2017-02-28
Primary completion: 2017-02-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.